| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shoulder Joint | 18 | 2024 | 91 | 4.910 |
Why?
|
| Rotator Cuff Injuries | 10 | 2022 | 43 | 4.380 |
Why?
|
| Rotator Cuff | 11 | 2022 | 41 | 3.290 |
Why?
|
| Arthroscopy | 15 | 2022 | 93 | 3.280 |
Why?
|
| Joint Diseases | 6 | 2020 | 48 | 2.230 |
Why?
|
| Elbow Joint | 4 | 2022 | 30 | 1.600 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2023 | 266 | 1.510 |
Why?
|
| Orthopedic Procedures | 5 | 2020 | 129 | 1.490 |
Why?
|
| Arthroplasty, Replacement | 5 | 2015 | 37 | 1.480 |
Why?
|
| Tendon Injuries | 3 | 2022 | 36 | 1.420 |
Why?
|
| Surgical Wound Infection | 4 | 2020 | 201 | 1.380 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 4 | 2023 | 25 | 1.340 |
Why?
|
| Retrospective Studies | 39 | 2022 | 9003 | 1.240 |
Why?
|
| Reoperation | 8 | 2021 | 598 | 1.180 |
Why?
|
| Shoulder Injuries | 5 | 2020 | 17 | 1.110 |
Why?
|
| Injections, Intra-Articular | 6 | 2022 | 27 | 1.070 |
Why?
|
| Analgesics, Opioid | 5 | 2020 | 442 | 1.040 |
Why?
|
| Shoulder Fractures | 2 | 2023 | 6 | 1.010 |
Why?
|
| Bursitis | 2 | 2022 | 10 | 0.970 |
Why?
|
| Shoulder | 5 | 2022 | 42 | 0.960 |
Why?
|
| Shoulder Dislocation | 3 | 2020 | 17 | 0.940 |
Why?
|
| Arthroplasty, Replacement, Hip | 6 | 2022 | 101 | 0.940 |
Why?
|
| Joint Instability | 4 | 2020 | 82 | 0.920 |
Why?
|
| Knee Joint | 6 | 2022 | 165 | 0.910 |
Why?
|
| Spinal Fusion | 6 | 2020 | 86 | 0.860 |
Why?
|
| Preoperative Period | 3 | 2020 | 94 | 0.840 |
Why?
|
| Humans | 92 | 2024 | 89073 | 0.840 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2022 | 169 | 0.830 |
Why?
|
| Arthroplasty, Replacement, Knee | 5 | 2022 | 114 | 0.810 |
Why?
|
| Tennis Elbow | 1 | 2021 | 12 | 0.780 |
Why?
|
| Coracoid Process | 2 | 2020 | 3 | 0.750 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 306 | 0.750 |
Why?
|
| Myocardial Ischemia | 1 | 2022 | 161 | 0.750 |
Why?
|
| Tenodesis | 2 | 2020 | 6 | 0.730 |
Why?
|
| Diskectomy | 5 | 2020 | 20 | 0.730 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 12 | 0.730 |
Why?
|
| Radius Fractures | 1 | 2020 | 33 | 0.700 |
Why?
|
| Lumbar Vertebrae | 5 | 2020 | 151 | 0.700 |
Why?
|
| Fibula | 1 | 2020 | 32 | 0.700 |
Why?
|
| Male | 48 | 2022 | 42254 | 0.680 |
Why?
|
| Middle Aged | 40 | 2022 | 25865 | 0.660 |
Why?
|
| Humerus | 6 | 2024 | 31 | 0.660 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 219 | 0.660 |
Why?
|
| Postoperative Complications | 10 | 2022 | 2275 | 0.650 |
Why?
|
| Aged | 27 | 2023 | 19078 | 0.630 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2016 | 127 | 0.610 |
Why?
|
| Range of Motion, Articular | 9 | 2024 | 154 | 0.610 |
Why?
|
| Arthritis, Infectious | 1 | 2017 | 16 | 0.590 |
Why?
|
| Lacerations | 2 | 2015 | 28 | 0.560 |
Why?
|
| Adult | 34 | 2021 | 26508 | 0.560 |
Why?
|
| Tendon Transfer | 2 | 2020 | 6 | 0.560 |
Why?
|
| Arthroplasty | 2 | 2023 | 28 | 0.560 |
Why?
|
| Female | 44 | 2022 | 46014 | 0.550 |
Why?
|
| Patient Care Team | 2 | 2018 | 283 | 0.550 |
Why?
|
| Tenocytes | 1 | 2016 | 4 | 0.540 |
Why?
|
| Achilles Tendon | 1 | 2016 | 15 | 0.540 |
Why?
|
| Rupture | 4 | 2022 | 61 | 0.530 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2014 | 91 | 0.530 |
Why?
|
| Glucocorticoids | 4 | 2023 | 357 | 0.530 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 257 | 0.520 |
Why?
|
| Treatment Outcome | 14 | 2023 | 8203 | 0.520 |
Why?
|
| Family | 1 | 2017 | 325 | 0.520 |
Why?
|
| Wound Healing | 2 | 2014 | 359 | 0.500 |
Why?
|
| Databases, Factual | 10 | 2021 | 850 | 0.500 |
Why?
|
| Osteoarthritis | 1 | 2015 | 74 | 0.490 |
Why?
|
| Informed Consent | 1 | 2017 | 275 | 0.490 |
Why?
|
| Platelet-Rich Plasma | 1 | 2014 | 11 | 0.480 |
Why?
|
| Cell Differentiation | 9 | 2016 | 1521 | 0.480 |
Why?
|
| Communication | 1 | 2018 | 457 | 0.480 |
Why?
|
| Osteotomy | 1 | 2014 | 33 | 0.480 |
Why?
|
| Ligaments, Articular | 5 | 2022 | 38 | 0.470 |
Why?
|
| Growth Differentiation Factor 2 | 5 | 2016 | 151 | 0.470 |
Why?
|
| Spondylitis, Ankylosing | 4 | 2015 | 25 | 0.460 |
Why?
|
| Pain Management | 1 | 2015 | 137 | 0.460 |
Why?
|
| Osteogenesis | 5 | 2016 | 255 | 0.440 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 643 | 0.430 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 531 | 0.430 |
Why?
|
| Connective Tissue Diseases | 1 | 2013 | 70 | 0.430 |
Why?
|
| Risk Factors | 11 | 2023 | 5466 | 0.420 |
Why?
|
| Osteochondritis Dissecans | 1 | 2012 | 5 | 0.410 |
Why?
|
| Thymus Gland | 1 | 2013 | 197 | 0.410 |
Why?
|
| Acromioclavicular Joint | 2 | 2024 | 5 | 0.410 |
Why?
|
| Adipose Tissue | 2 | 2014 | 259 | 0.400 |
Why?
|
| Th17 Cells | 2 | 2011 | 84 | 0.390 |
Why?
|
| United States | 11 | 2022 | 6957 | 0.380 |
Why?
|
| Homeostasis | 1 | 2013 | 413 | 0.380 |
Why?
|
| Young Adult | 12 | 2020 | 6289 | 0.370 |
Why?
|
| Glycolysis | 1 | 2011 | 135 | 0.360 |
Why?
|
| Fractures, Bone | 2 | 2022 | 127 | 0.360 |
Why?
|
| Cohort Studies | 7 | 2022 | 2863 | 0.350 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 155 | 0.350 |
Why?
|
| Soft Tissue Injuries | 3 | 2014 | 13 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2015 | 2399 | 0.340 |
Why?
|
| Debridement | 3 | 2019 | 57 | 0.340 |
Why?
|
| Biomechanical Phenomena | 6 | 2024 | 473 | 0.330 |
Why?
|
| Humeral Fractures | 2 | 2023 | 17 | 0.330 |
Why?
|
| Obesity | 1 | 2015 | 966 | 0.320 |
Why?
|
| Pain, Postoperative | 3 | 2020 | 251 | 0.320 |
Why?
|
| Joint Prosthesis | 2 | 2011 | 26 | 0.320 |
Why?
|
| HEK293 Cells | 9 | 2016 | 638 | 0.320 |
Why?
|
| Adolescent | 11 | 2020 | 9237 | 0.320 |
Why?
|
| Comorbidity | 4 | 2021 | 948 | 0.310 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2019 | 75 | 0.300 |
Why?
|
| Femoral Fractures | 2 | 2022 | 27 | 0.300 |
Why?
|
| Tendons | 2 | 2020 | 44 | 0.300 |
Why?
|
| Cerebrospinal Fluid | 1 | 2007 | 31 | 0.300 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 6777 | 0.290 |
Why?
|
| Scapula | 3 | 2024 | 24 | 0.290 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1241 | 0.290 |
Why?
|
| Blood-Brain Barrier | 1 | 2007 | 74 | 0.290 |
Why?
|
| Contracture | 2 | 2020 | 18 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2022 | 3443 | 0.280 |
Why?
|
| Spinal Fractures | 2 | 2022 | 77 | 0.270 |
Why?
|
| Tight Junctions | 1 | 2007 | 150 | 0.270 |
Why?
|
| Mice | 14 | 2024 | 11742 | 0.270 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 91 | 0.270 |
Why?
|
| Carrier Proteins | 3 | 2015 | 681 | 0.270 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2016 | 47 | 0.250 |
Why?
|
| Transcription Factors | 1 | 2013 | 1652 | 0.250 |
Why?
|
| Animals | 19 | 2024 | 27324 | 0.250 |
Why?
|
| Gene Expression | 3 | 2014 | 1310 | 0.240 |
Why?
|
| Injections | 2 | 2021 | 116 | 0.240 |
Why?
|
| Staphylococcus epidermidis | 1 | 2024 | 15 | 0.240 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 2 | 2015 | 4 | 0.240 |
Why?
|
| Lumbosacral Region | 3 | 2020 | 27 | 0.240 |
Why?
|
| Cervical Vertebrae | 2 | 2019 | 81 | 0.230 |
Why?
|
| Hydrogels | 1 | 2024 | 86 | 0.230 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 282 | 0.230 |
Why?
|
| Chondrocytes | 2 | 2014 | 64 | 0.220 |
Why?
|
| Odds Ratio | 3 | 2020 | 684 | 0.220 |
Why?
|
| DNA Transposable Elements | 2 | 2014 | 174 | 0.220 |
Why?
|
| Trigger Finger Disorder | 1 | 2023 | 5 | 0.220 |
Why?
|
| Fractures, Comminuted | 1 | 2023 | 6 | 0.220 |
Why?
|
| Cartilage, Articular | 2 | 2014 | 69 | 0.220 |
Why?
|
| Physical Therapy Modalities | 2 | 2022 | 83 | 0.220 |
Why?
|
| Triangular Fibrocartilage | 1 | 2022 | 1 | 0.210 |
Why?
|
| Radiography | 3 | 2014 | 809 | 0.210 |
Why?
|
| Postoperative Period | 2 | 2020 | 301 | 0.210 |
Why?
|
| Wrist Joint | 1 | 2022 | 24 | 0.210 |
Why?
|
| Logistic Models | 3 | 2020 | 1212 | 0.210 |
Why?
|
| Tissue Scaffolds | 2 | 2013 | 111 | 0.210 |
Why?
|
| Anesthetics, Local | 2 | 2020 | 76 | 0.210 |
Why?
|
| Hip Fractures | 1 | 2022 | 46 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 313 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2015 | 2335 | 0.200 |
Why?
|
| Tenosynovitis | 1 | 2021 | 7 | 0.190 |
Why?
|
| De Quervain Disease | 1 | 2021 | 7 | 0.190 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 66 | 0.190 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2018 | 7 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 887 | 0.190 |
Why?
|
| Certificate of Need | 1 | 2021 | 3 | 0.190 |
Why?
|
| Cell Line, Transformed | 3 | 2016 | 155 | 0.190 |
Why?
|
| Polyradiculopathy | 1 | 2021 | 5 | 0.190 |
Why?
|
| Psoriasis | 1 | 2024 | 245 | 0.190 |
Why?
|
| Cauda Equina | 1 | 2021 | 12 | 0.190 |
Why?
|
| Lymphedema | 1 | 2022 | 77 | 0.190 |
Why?
|
| Femoral Neck Fractures | 1 | 2020 | 9 | 0.190 |
Why?
|
| Prosthesis-Related Infections | 2 | 2011 | 60 | 0.180 |
Why?
|
| Skin | 1 | 2024 | 581 | 0.180 |
Why?
|
| Trans-Activators | 2 | 2013 | 443 | 0.180 |
Why?
|
| Sepsis | 2 | 2017 | 319 | 0.180 |
Why?
|
| Injections, Epidural | 1 | 2020 | 6 | 0.180 |
Why?
|
| Steroids | 1 | 2021 | 174 | 0.180 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2020 | 17 | 0.180 |
Why?
|
| Low Back Pain | 1 | 2020 | 41 | 0.180 |
Why?
|
| New York | 1 | 2020 | 72 | 0.180 |
Why?
|
| Transplant Donor Site | 1 | 2020 | 3 | 0.180 |
Why?
|
| Back Pain | 1 | 2020 | 42 | 0.180 |
Why?
|
| Hypertrophy | 1 | 2020 | 67 | 0.180 |
Why?
|
| Ankle | 1 | 2020 | 20 | 0.180 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2019 | 12 | 0.170 |
Why?
|
| Sciatic Nerve | 1 | 2019 | 34 | 0.170 |
Why?
|
| Femoral Nerve | 1 | 2019 | 8 | 0.170 |
Why?
|
| Foot | 1 | 2020 | 52 | 0.170 |
Why?
|
| Ankle Joint | 1 | 2020 | 46 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2612 | 0.170 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 46 | 0.170 |
Why?
|
| Aspirin | 1 | 2020 | 159 | 0.170 |
Why?
|
| Internal Fixators | 1 | 2019 | 14 | 0.170 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 479 | 0.170 |
Why?
|
| Adenoviridae | 3 | 2015 | 349 | 0.160 |
Why?
|
| Health Policy | 1 | 2021 | 184 | 0.160 |
Why?
|
| Arthrodesis | 2 | 2021 | 26 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 3211 | 0.160 |
Why?
|
| Hip Dislocation | 1 | 2018 | 9 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2021 | 235 | 0.160 |
Why?
|
| Incidence | 2 | 2021 | 1592 | 0.160 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 726 | 0.160 |
Why?
|
| Cell Survival | 3 | 2016 | 982 | 0.160 |
Why?
|
| Health Status Indicators | 1 | 2019 | 103 | 0.160 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2018 | 22 | 0.160 |
Why?
|
| Medicare | 1 | 2022 | 423 | 0.160 |
Why?
|
| Decompression, Surgical | 4 | 2021 | 87 | 0.150 |
Why?
|
| Allografts | 1 | 2019 | 181 | 0.150 |
Why?
|
| Nursing Staff, Hospital | 1 | 2018 | 42 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 988 | 0.150 |
Why?
|
| Spinal Diseases | 1 | 2018 | 44 | 0.150 |
Why?
|
| Laminectomy | 1 | 2017 | 27 | 0.150 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 159 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2020 | 292 | 0.150 |
Why?
|
| Chemoprevention | 1 | 2018 | 92 | 0.150 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 3657 | 0.150 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 894 | 0.150 |
Why?
|
| Pain Measurement | 2 | 2020 | 328 | 0.150 |
Why?
|
| Patient Comfort | 1 | 2017 | 7 | 0.150 |
Why?
|
| Training Support | 1 | 2017 | 23 | 0.150 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 108 | 0.150 |
Why?
|
| Outpatients | 1 | 2017 | 100 | 0.150 |
Why?
|
| Thromboembolism | 1 | 2018 | 120 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2020 | 948 | 0.140 |
Why?
|
| Child | 3 | 2020 | 7149 | 0.140 |
Why?
|
| Arthrography | 1 | 2016 | 6 | 0.140 |
Why?
|
| Spine | 1 | 2017 | 102 | 0.140 |
Why?
|
| Nerve Compression Syndromes | 2 | 2014 | 18 | 0.140 |
Why?
|
| Preoperative Care | 2 | 2020 | 396 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2022 | 771 | 0.140 |
Why?
|
| Transduction, Genetic | 2 | 2015 | 160 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2017 | 280 | 0.140 |
Why?
|
| Child, Preschool | 2 | 2022 | 3717 | 0.140 |
Why?
|
| Receptors, Interferon | 1 | 2016 | 31 | 0.140 |
Why?
|
| Transgenes | 2 | 2014 | 185 | 0.140 |
Why?
|
| Models, Anatomic | 1 | 2016 | 91 | 0.140 |
Why?
|
| Mice, Knockout | 3 | 2024 | 1990 | 0.140 |
Why?
|
| Muscular Atrophy | 2 | 2014 | 46 | 0.140 |
Why?
|
| Electromyography | 2 | 2014 | 193 | 0.140 |
Why?
|
| CTLA-4 Antigen | 1 | 2016 | 139 | 0.130 |
Why?
|
| Time Factors | 3 | 2020 | 5320 | 0.130 |
Why?
|
| Benchmarking | 3 | 2023 | 79 | 0.130 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2016 | 32 | 0.130 |
Why?
|
| Operating Rooms | 1 | 2017 | 129 | 0.130 |
Why?
|
| Intervertebral Disc | 1 | 2015 | 16 | 0.130 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 110 | 0.130 |
Why?
|
| Cell Shape | 1 | 2016 | 51 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 385 | 0.130 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 135 | 0.130 |
Why?
|
| Femur Head Necrosis | 1 | 2015 | 4 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1650 | 0.130 |
Why?
|
| Operative Time | 1 | 2015 | 142 | 0.120 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2015 | 27 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Elbow | 1 | 2014 | 2 | 0.120 |
Why?
|
| Collagen Type III | 1 | 2014 | 4 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2014 | 29 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2013 | 3374 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 269 | 0.120 |
Why?
|
| Interferon-gamma | 1 | 2016 | 451 | 0.120 |
Why?
|
| Simian virus 40 | 1 | 2014 | 35 | 0.120 |
Why?
|
| Biomarkers | 3 | 2016 | 1755 | 0.120 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 19 | 0.120 |
Why?
|
| Chondrogenesis | 1 | 2014 | 28 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 275 | 0.120 |
Why?
|
| Cell Line | 4 | 2015 | 2495 | 0.120 |
Why?
|
| Microscopy | 1 | 2014 | 87 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 89 | 0.120 |
Why?
|
| China | 4 | 2016 | 233 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 1837 | 0.120 |
Why?
|
| Wnt3A Protein | 1 | 2013 | 23 | 0.120 |
Why?
|
| Fibronectins | 1 | 2014 | 101 | 0.120 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 2013 | 1 | 0.120 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2013 | 5 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 956 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2013 | 25 | 0.110 |
Why?
|
| Ribs | 1 | 2013 | 46 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2014 | 287 | 0.110 |
Why?
|
| Neural Conduction | 1 | 2013 | 71 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 207 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 309 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2014 | 130 | 0.110 |
Why?
|
| Bone Regeneration | 1 | 2013 | 59 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2013 | 2880 | 0.110 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 253 | 0.110 |
Why?
|
| Receptor Cross-Talk | 1 | 2013 | 34 | 0.110 |
Why?
|
| Infant | 1 | 2020 | 3147 | 0.110 |
Why?
|
| Osteoblasts | 1 | 2013 | 98 | 0.110 |
Why?
|
| Models, Animal | 1 | 2014 | 276 | 0.110 |
Why?
|
| Growth Differentiation Factors | 1 | 2013 | 57 | 0.110 |
Why?
|
| Epidermal Growth Factor | 1 | 2013 | 117 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 127 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 97 | 0.110 |
Why?
|
| Chicago | 1 | 2017 | 1423 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 167 | 0.110 |
Why?
|
| Interleukin-2 | 1 | 2013 | 251 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 616 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2014 | 261 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 147 | 0.100 |
Why?
|
| Polyesters | 2 | 2013 | 41 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 421 | 0.100 |
Why?
|
| Opioid-Related Disorders | 3 | 2020 | 185 | 0.100 |
Why?
|
| Melanoma | 1 | 2016 | 467 | 0.100 |
Why?
|
| Bone Cements | 1 | 2011 | 9 | 0.100 |
Why?
|
| beta Catenin | 1 | 2013 | 266 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 727 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 255 | 0.100 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2011 | 17 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1237 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 691 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 579 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 901 | 0.100 |
Why?
|
| Fracture Fixation, Internal | 2 | 2023 | 66 | 0.100 |
Why?
|
| Arm | 2 | 2022 | 97 | 0.100 |
Why?
|
| Candidiasis | 1 | 2011 | 37 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 61 | 0.090 |
Why?
|
| Stem Cells | 1 | 2013 | 372 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2014 | 755 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2019 | 4273 | 0.090 |
Why?
|
| Fractures, Open | 1 | 2010 | 10 | 0.090 |
Why?
|
| Bone Nails | 1 | 2010 | 15 | 0.090 |
Why?
|
| Listeriosis | 1 | 2011 | 86 | 0.090 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2010 | 12 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2013 | 370 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2024 | 595 | 0.090 |
Why?
|
| DNA Primers | 1 | 2011 | 543 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 171 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 179 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2014 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 1401 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 185 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1715 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 786 | 0.080 |
Why?
|
| Thoracic Vertebrae | 1 | 2009 | 51 | 0.080 |
Why?
|
| Thoracic Injuries | 1 | 2009 | 38 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 3000 | 0.080 |
Why?
|
| Absorbable Implants | 1 | 2008 | 34 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2011 | 442 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1041 | 0.070 |
Why?
|
| Choroid Plexus | 1 | 2007 | 15 | 0.070 |
Why?
|
| Claudin-1 | 1 | 2007 | 17 | 0.070 |
Why?
|
| Occludin | 1 | 2007 | 66 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1574 | 0.070 |
Why?
|
| Base Sequence | 1 | 2011 | 2327 | 0.070 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2007 | 70 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 136 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 306 | 0.070 |
Why?
|
| Biological Transport | 1 | 2007 | 401 | 0.070 |
Why?
|
| Prosthesis Design | 1 | 2007 | 296 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2007 | 261 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 996 | 0.070 |
Why?
|
| Genotype | 3 | 2015 | 1848 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 848 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2014 | 1855 | 0.060 |
Why?
|
| Electronics | 1 | 2024 | 17 | 0.060 |
Why?
|
| Wireless Technology | 1 | 2024 | 21 | 0.060 |
Why?
|
| Acromion | 1 | 2024 | 3 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2024 | 35 | 0.060 |
Why?
|
| Humidity | 1 | 2024 | 92 | 0.060 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 26 | 0.060 |
Why?
|
| Body Temperature | 1 | 2024 | 124 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2024 | 110 | 0.060 |
Why?
|
| Alkaline Phosphatase | 2 | 2013 | 132 | 0.060 |
Why?
|
| Cell Separation | 2 | 2014 | 198 | 0.060 |
Why?
|
| Choristoma | 2 | 2013 | 68 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2007 | 688 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2014 | 178 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2014 | 153 | 0.050 |
Why?
|
| Ulna | 1 | 2022 | 15 | 0.050 |
Why?
|
| Acetabulum | 1 | 2022 | 27 | 0.050 |
Why?
|
| Ligaments | 1 | 2022 | 33 | 0.050 |
Why?
|
| Cadaver | 1 | 2022 | 185 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 244 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2014 | 446 | 0.050 |
Why?
|
| Femur | 1 | 2022 | 111 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2022 | 49 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2013 | 477 | 0.050 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 258 | 0.050 |
Why?
|
| Hospitalization | 2 | 2019 | 876 | 0.050 |
Why?
|
| Drainage | 1 | 2022 | 162 | 0.050 |
Why?
|
| Rats | 1 | 2007 | 4041 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1215 | 0.050 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 45 | 0.050 |
Why?
|
| Bone Screws | 1 | 2020 | 45 | 0.050 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 78 | 0.050 |
Why?
|
| Tissue Adhesions | 1 | 2020 | 49 | 0.050 |
Why?
|
| Alleles | 2 | 2014 | 1135 | 0.040 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2020 | 40 | 0.040 |
Why?
|
| Cytokines | 2 | 2016 | 802 | 0.040 |
Why?
|
| Trauma, Nervous System | 1 | 2019 | 5 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2020 | 78 | 0.040 |
Why?
|
| Hip Joint | 1 | 2019 | 54 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 126 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 2019 | 110 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2021 | 246 | 0.040 |
Why?
|
| Regeneration | 1 | 2020 | 150 | 0.040 |
Why?
|
| Betamethasone | 1 | 2018 | 5 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 343 | 0.040 |
Why?
|
| Humeral Head | 1 | 2018 | 5 | 0.040 |
Why?
|
| Oxycodone | 1 | 2018 | 35 | 0.040 |
Why?
|
| Joint Dislocations | 1 | 2018 | 27 | 0.040 |
Why?
|
| Anesthesia | 1 | 2020 | 169 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 2018 | 33 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 971 | 0.040 |
Why?
|
| Lidocaine | 1 | 2018 | 65 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2018 | 122 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2019 | 234 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2018 | 202 | 0.040 |
Why?
|
| Family Relations | 1 | 2017 | 35 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2020 | 426 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 111 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 250 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 228 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 996 | 0.030 |
Why?
|
| Ipilimumab | 1 | 2016 | 61 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 174 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 104 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 447 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 247 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2015 | 67 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 345 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 103 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2019 | 351 | 0.030 |
Why?
|
| HLA-B27 Antigen | 1 | 2015 | 8 | 0.030 |
Why?
|
| Subcutaneous Tissue | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2014 | 39 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2014 | 15 | 0.030 |
Why?
|
| Tennis | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fibrocartilage | 1 | 2014 | 1 | 0.030 |
Why?
|
| Integrases | 1 | 2014 | 62 | 0.030 |
Why?
|
| Acetylation | 1 | 2014 | 132 | 0.030 |
Why?
|
| Arthralgia | 1 | 2014 | 39 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 23 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2014 | 52 | 0.030 |
Why?
|
| Durapatite | 1 | 2013 | 28 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 221 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 1012 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 2014 | 60 | 0.030 |
Why?
|
| Bone Matrix | 1 | 2013 | 19 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2013 | 33 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2013 | 43 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 275 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 72 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 599 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2014 | 170 | 0.030 |
Why?
|
| Calcium Phosphates | 1 | 2013 | 77 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 294 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 1090 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2013 | 92 | 0.030 |
Why?
|
| Estradiol | 1 | 2013 | 250 | 0.030 |
Why?
|
| Estrogens | 1 | 2013 | 201 | 0.030 |
Why?
|
| Electrodiagnosis | 1 | 2012 | 7 | 0.030 |
Why?
|
| Extremities | 1 | 2013 | 169 | 0.030 |
Why?
|
| Fetus | 1 | 2013 | 232 | 0.030 |
Why?
|
| Rabbits | 1 | 2013 | 638 | 0.030 |
Why?
|
| Acrylates | 1 | 2011 | 18 | 0.030 |
Why?
|
| Polymers | 1 | 2013 | 194 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 685 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 329 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 625 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1706 | 0.020 |
Why?
|
| Th1-Th2 Balance | 1 | 2011 | 4 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 814 | 0.020 |
Why?
|
| STAT4 Transcription Factor | 1 | 2011 | 10 | 0.020 |
Why?
|
| Haplotypes | 1 | 2013 | 637 | 0.020 |
Why?
|
| Inpatients | 1 | 2014 | 310 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 85 | 0.020 |
Why?
|
| Physical Examination | 1 | 2012 | 148 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 732 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 169 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 444 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 123 | 0.020 |
Why?
|
| Multiple Trauma | 1 | 2010 | 34 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 162 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 1662 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2553 | 0.020 |
Why?
|
| Cell Communication | 1 | 2011 | 199 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2011 | 166 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2013 | 500 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 167 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1223 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2010 | 144 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 242 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2014 | 657 | 0.020 |
Why?
|
| Kyphosis | 1 | 2009 | 14 | 0.020 |
Why?
|
| Sheep, Domestic | 1 | 2008 | 9 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2011 | 429 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2439 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2657 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1975 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 2291 | 0.010 |
Why?
|